AB 2280: Information privacy: personal health record information: software or hardware.
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2020-07-14
|
Date
|
Status
|
|---|---|
| Jul 14, 2020 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on JUD. |
| Jul 1, 2020 | Referred to Com. on JUD. |
| Jun 11, 2020 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 10, 2020 | Read third time. Passed. Ordered to the Senate. (Ayes 53. Noes 10. Page 4760.) |
| Jun 4, 2020 | Read second time. Ordered to third reading. |
| Jun 3, 2020 | From committee: Do pass. (Ayes 12. Noes 1.) (June 3). |
| Jun 2, 2020 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| May 19, 2020 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 10. Noes 0.) (May 18). Re-referred to Com. on APPR. |
| Mar 17, 2020 | In committee: Hearing postponed by committee. |
| Feb 24, 2020 | Referred to Coms. on HEALTH and P. & C.P. |
| Feb 15, 2020 | From printer. May be heard in committee March 16. |
| Feb 14, 2020 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jun 10, 2020 | AB 2280 Chau Assembly Third Reading | Assembly Floor |
Passed |
|
| Jun 3, 2020 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| May 18, 2020 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
ASSEMBLY THIRD READING
ATR Bill Id:AB 2280
Author:(Chau)
As Introduced Ver:February 14, 2020
Majority vote
SUMMARY:
Revises the Confidentiality of Medical Information Act (CMIA) to define personal health record and personal health record information. Deems a business that offers personal health record software or hardware to a consumer, as specified, for purposes of allowing the individual to manage their information, or for the diagnosis, treatment, or management of a medical condition of the individual, to be a health care provider subject to the requirements of the CMIA.
Major Provisions
- Defines the following:
- Personal health record as a U.S. Food and Drug Administration (FDA)-approved commercial internet website, online service, or product that is used by an individual at the direction of a provider of health care with the primary purpose of collecting the individual's individually identifiable personal health record information.
- Personal health record information as individually identifiable information, in electronic or physical form, about an individual's mental or physical condition that is collected by a personal health record through a direct measurement of an individual's mental or physical condition or through user input regarding an individual's mental or physical condition into a personal health record.
- Deems any business that offers personal health record software or hardware to a consumer, including a mobile application or other related device that is designed to maintain personal health record information, as defined, in order to make information available to an individual or to a provider of health care at the request of the individual or provider of health care, for purposes of allowing the individual to manage their information, or for the diagnosis, treatment, or management of a medical condition of the individual, to be a provider of health care, as specified.
- Makes other technical and conforming changes.
COMMENTS:
The FDA encourages the development of mobile medical apps (MMAs) that improve health care and provide consumers and health care professionals with valuable health information. The FDA also has a public health responsibility to oversee the safety and effectiveness of medical devices, including MMAs. The Policy for Device Software Functions and Mobile Medical Applications Guidance, first issued in 2013 as "Mobile Medical Applications" (MMA guidance) and updated in 2015 and 2019, explains the agency's oversight of device software functions, including mobile medical apps, as devices and our focus only on the software that presents a greater risk to patients if it does not work as intended and on software that causes smartphones, computers, or other mobile platforms to impact the functionality or performance of traditional medical devices. According to the FDA, mobile apps are software programs that run on smartphones and other mobile communication devices. They can also be accessories that attach to a smartphone or other mobile communication devices, or a combination of accessories and software.
MMAs are medical devices that are mobile apps, meet the definition of a medical device, and are an accessory to a regulated medical device or transform a mobile platform into a regulated medical device. Consumers can use both MMAs and mobile apps to manage their own health and wellness, such as to monitor their caloric intake for healthy weight maintenance. For example, the National Institutes of Health's LactMed app provides nursing mothers with information about the effects of medicines on breast milk and nursing infants. Other apps aim to help health care professionals improve and facilitate patient care. The Radiation Emergency Medical Management app gives health care providers guidance on diagnosing and treating radiation injuries. Some MMAs can diagnose cancer or heart rhythm abnormalities, or function as the "central command" for a glucose meter used by an insulin-dependent diabetic patient.
A 2017 New York Times article described that for the first time, the FDA has approved a digital pill, specifically, a medication embedded with a sensor that can tell doctors whether, and when, patients take their medicine. This approval marks a significant advance in the growing field of digital devices designed to monitor medicine-taking and to address the issue of patients not taking drugs as prescribed. The article notes that experts estimate that so-called nonadherence or noncompliance to medication costs about $100 billion a year because patients get sicker and need additional treatment or hospitalization. Patients who agree to take the digital medication can sign consent forms allowing their doctors and up to four other people, including family members, to receive electronic data showing the date and time pills are ingested. A smartphone app will allow patients to block recipients anytime they change their mind. Although voluntary, the technology is still likely to prompt questions about privacy and whether patients might feel pressured to take medication in a form their doctors can monitor. The article also notes that companies are developing digital medication technologies, including another ingestible sensor and visual recognition technology capable of confirming whether a patient has placed a pill on the tongue and has swallowed it and not all will need regulatory clearance, and some are already being used or tested in patients with heart problems, stroke, HIV, diabetes and other conditions.
According to the Author:
According to the author, while technology stands to improve how healthcare is delivered, these advancements do not come without risk. Health and medical information is, by its very nature, deeply personal and sensitive. New technology makes medical information easily and quickly accessible via apps and websites, and California has ensured that medical information held by mobile devices is protected under our privacy laws. However, in order to be considered "medical information," this information generally needs to be generated by a healthcare provider. The author states that information generated by a digital health feedback system, meaning at the patient level and outside of a medical facility, is not necessarily captured under the existing definition of medical information. However, information about whether a patient took their medication and how that medication interacted in their body is unquestionably of a medical nature. The author concludes that it is imperative that the information generated by digital health feedback systems is classified as medical information, and developers and operators of hardware, software, and applications are prohibited from sharing this information and data without the patient's informed consent.
Arguments in Support:
The California Telehealth Policy Coalition writes that this bill would provide Californians with added privacy protections that can help to safeguard their data and extend protections to the burgeoning field of FDA-approved digital health products. The National Association of Social Workers, California Chapter, states that despite digital health's potential for a positive impact, there are significant concerns related to privacy and data security, which may act as barriers to its success. This bill would ensure that personal health information collected by these digital products is subject to CMIA, thereby ensuring patient privacy protections, while still allowing for the sharing of health information, as necessary, for the diagnosis and treatment of patients.
Arguments in Support if Amended:
Consumer Reports (CR) writes that although CR strongly support broadening the scope of this bill, this bill limits the application of this bill to health technology that is both FDA-approved and used at the direction of a healthcare provider, is overly restrictive and risks significant confusion.
Arguments in Opposition:
A coalition of opposition writes that innovation in the medical technology industry benefits patients and our healthcare system, with the promise of producing millions in savings. This bill would increase compliance, legal and other administrative costs, while discouraging investment in this beneficial technology, without evidence of a well-documented problem in the already heavily regulated space of connected medical technology. This bill could therefore be a solution in search of a problem and creating unintended consequences for emerging technologies that could help to dramatically improve patient care.
FISCAL COMMENTS:
According to the Assembly Appropriations, increased staff costs of $370,000 to the Department of Justice, Public Rights Division for an anticipated increase in enforcement actions against violators (General Fund).
VOTES:
ASM HEALTH: 10-0-5
YES: Wood, Aguiar-Curry, Bonta, Carrillo, Limón, McCarty, Nazarian, Ramos, Rodriguez, Santiago
ABS, ABST OR NV: Mayes, Bigelow, Burke, Flora, Waldron
ASM APPROPRIATIONS: 12-1-5
YES: Gonzalez, Bauer-Kahan, Bloom, Bonta, Calderon, Carrillo, Chau, Eggman, Gabriel, Eduardo Garcia, McCarty, Robert Rivas
NO: Diep
ABS, ABST OR NV: Bigelow, Megan Dahle, Fong, Petrie-Norris, Voepel
UPDATED:
VERSION: February 14, 2020
CONSULTANT: Kristene Mapile / HEALTH / (916) 319-2097 FN: 0002883
Date of Hearing: June 2, 2020
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 2280
Author:(Chau) – As Introduced Ver:February 14, 2020
Policy Committee: | Health | Vote: | 10 - 0 |
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
For purposes of the California Medical Information Act (CMIA), this bill defines “personal health record” and “personal health record information” to encompass data collected through, and platforms that collect and share data through, digital health feedback systems such as smart phone apps or connected devices, and makes information collected and shared through such products subject to privacy protections in the CMIA.
FISCAL EFFECT:
Increased staff costs of $370,000 to the Department of Justice, Public Rights Division for an anticipated increase in enforcement actions against violators (GF).
COMMENTS:
- Purpose. According to the author, California ensures medical information held by mobile devices is protected under our privacy laws. However, to be considered “medical information,” this information generally needs to be generated by a healthcare provider. This bill would ensure modern health data monitoring tools fall under the same privacy regime as health care data generated in a more traditional health care setting.
- Confidentiality of Health Information. Existing state law (the CMIA) and federal laws including federal Health Insurance Portability and Accountability Act (HIPAA) protect the confidentiality of health information. Under California law, the state Attorney General, a county council, district attorney or city attorney may bring a civil action to enforce CMIA and individuals may sue for damages arising from any negligent release of confidential information.
Information generated by modern digital health systems, however, would not necessarily be captured under the existing definitions. These systems might include, for instance, apps that track heart rate or digital pills that monitor levels of a drug in the bloodstream. Protected medical and health information under state and federal law generally receives a classification as protected only because the information originates with a health care provider or other "covered entity," as defined in current law. This bill would subject a business that offers personal health record software or hardware, as specified, to existing confidentiality provisions of state law by deeming such a business a “provider of healthcare” for purposes of the law.
- Support and Opposition. This bill is supported by the California Telehealth Policy Coalition, National Association of Social Workers, California Chapter, and Oakland Privacy, who argue this bill closes a loophole that has resulted from rapid technological innovation. It is opposed by drug and device manufacturers, as well as CalChamber, who argue the bill will stifle innovation. Opponents note the federal Food and Drug Administration intends to address this issue in a recently released Digital Health Innovation Action Plan.
- Prior Legislation. AB 384 (Chau), of the current session, is similar to this bill and was held on the Suspense File of the Senate Appropriations Committee.
AB 2167 (Chau), of the 2017-18 Legislation Session, is substantially similar to this bill and died on the Senate Floor.
AB 2935 (Chau), of the 2017-18 Legislation Session would have prohibited an operator of a commercial health monitoring program (CHMP) from intentionally sharing, selling or disclosing individually identifiable health monitoring information in its possession or derived from a CHMP without first obtaining the consumer’s consent. AB 2935 was referred to the Senate Judiciary Committee and never heard.
AB 375 (Chau), Chapter 55, Statutes of 2018, enacts the California Consumer Privacy Act of 2018, and grants a consumer a right to request a business to disclose the categories and specific pieces of personal information that it collects about the consumer, the categories of sources from which that information is collected, the business purposes for collecting or selling the information, and the categories of third parties with which the information is shared.
SB 1121 (Dodd), Chapter 735, Statutes of 2018, modifies the California Consumer Privacy Act of 2018, by requiring a business that collects personal information about a consumer to disclose the consumer’s right to delete personal information in a form that is reasonably accessible to consumers, as specified.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: May 18, 2020
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 2280
Author:(Chau) – As Introduced Ver:February 14, 2020
SUBJECT: Information privacy: digital health feedback systems.
SUMMARY: Revises the Confidentiality of Medical Information Act (CMIA) to define personal health record and personal health record information. Deems a business that offers personal health record software or hardware to a consumer, as specified, for purposes of allowing the individual to manage their information, or for the diagnosis, treatment, or management of a medical condition of the individual, to be a health care provider subject to the requirements of the CMIA. Specifically, this bill:
- Defines the following:
- Personal health record as a U.S. Food and Drug Administration (FDA)-approved commercial internet website, online service, or product that is used by an individual at the direction of a provider of health care with the primary purpose of collecting the individual’s individually identifiable personal health record information.
- Personal health record information as individually identifiable information, in electronic or physical form, about an individual’s mental or physical condition that is collected by a personal health record through a direct measurement of an individual’s mental or physical condition or through user input regarding an individual’s mental or physical condition into a personal health record.
- Deems any business that offers personal health record software or hardware to a consumer, including a mobile application or other related device that is designed to maintain personal health record information, as defined, in order to make information available to an individual or to a provider of health care at the request of the individual or provider of health care, for purposes of allowing the individual to manage their information, or for the diagnosis, treatment, or management of a medical condition of the individual, to be a provider of health care, as specified.
- Makes other technical and conforming changes.
EXISTING LAW:
- Establishes under federal law, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) which sets standards for privacy of individually identifiable health information and security standards for the protection of electronic protected health information, including, through regulations, that a HIPAA covered entity may not condition the provision of treatment, payment, enrollment in the health plan, or eligibility for benefits on the provision of an authorization, except under specified circumstances. Provides that if HIPAA’s provisions conflict with state law, the provision that is most protective of patient privacy prevails.
- Prohibits, under the state CMIA, a provider of health care, a health care service plan, a contractor, a corporation and its subsidiaries and affiliates, or any business that offers software or hardware to consumers, including a mobile application or other related device, as defined, from intentionally sharing, selling, using for marketing, or otherwise using any medical information, as defined, for any purpose not necessary to provide health care services to a patient, except as expressly authorized by the patient, enrollee, or subscriber, as specified, or as otherwise required or authorized by law. States that a violation of these provisions that results in economic loss or personal injury to a patient is a crime.
- Defines, for purposes of the CMIA, medical information to mean any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patient’s medical history, mental or physical condition, or treatment. Defines individually identifiable to mean that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patient’s name, address, electronic mail address, telephone number, social security number, or other information that, alone or in combination with other publicly available information, reveals the individual’s identity.
- Prohibits health care providers, health care service plans, or contractors, as defined, from sharing medical information without the patient’s written authorization, subject to certain exceptions.
- Deems any business organized for the purpose of maintaining medical information in order to make the information available to an individual or to a provider of health care at the request of the individual or the provider of health care, for purposes of allowing the individual to manage their information, or for the diagnosis and treatment of the individual, to be a health care provider subject to the requirements of the CMIA.
- Deems any business that offers software or hardware to consumers, including a mobile application or other related device that is designed to maintain medical information in order to make the information available to an individual or a provider of health care at the request of the individual or a provider of health care, for purposes of allowing the individual to manage their information, or for the diagnosis, treatment, or management of a medical condition of the individual, to be deemed to be a health care provider subject to the requirements of the CMIA.
FISCAL EFFECT: This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, while technology stands to improve how healthcare is delivered, these advancements do not come without risk. Health and medical information is, by its very nature, deeply personal and sensitive. New technology makes medical information easily and quickly accessible via apps and websites, and California has ensured that medical information held by mobile devices is protected under our privacy laws. However, in order to be considered “medical information,” this information generally needs to be generated by a healthcare provider. The author states that information generated by a digital health feedback system, meaning at the patient level and outside of a medical facility, is not necessarily captured under the existing definition of medical information. However, information about whether a patient took their medication and how that medication interacted in their body is unquestionably of a medical nature. The author concludes that it is imperative that the information generated by digital health feedback systems is classified as medical information, and developers and operators of hardware, software, and applications are prohibited from sharing this information and data without the patient’s informed consent.
- BACKGROUND.
- Mobile medical apps. The FDA encourages the development of mobile medical apps (MMAs) that improve health care and provide consumers and health care professionals with valuable health information. The FDA also has a public health responsibility to oversee the safety and effectiveness of medical devices, including MMAs.
The Policy for Device Software Functions and Mobile Medical Applications Guidance, first issued in 2013 as "Mobile Medical Applications" (MMA guidance) and updated in 2015 and 2019, explains the agency's oversight of device software functions, including mobile medical apps, as devices and our focus only on the software that presents a greater risk to patients if it does not work as intended and on software that causes smartphones, computers, or other mobile platforms to impact the functionality or performance of traditional medical devices.
According to the FDA, mobile apps are software programs that run on smartphones and other mobile communication devices. They can also be accessories that attach to a smartphone or other mobile communication devices, or a combination of accessories and software.
MMAs are medical devices that are mobile apps, meet the definition of a medical device, and are an accessory to a regulated medical device or transform a mobile platform into a regulated medical device.
Consumers can use both MMAs and mobile apps to manage their own health and wellness, such as to monitor their caloric intake for healthy weight maintenance. For example, the National Institutes of Health's LactMed app provides nursing mothers with information about the effects of medicines on breast milk and nursing infants.
Other apps aim to help health care professionals improve and facilitate patient care. The Radiation Emergency Medical Management app gives health care providers guidance on diagnosing and treating radiation injuries. Some MMAs can diagnose cancer or heart rhythm abnormalities, or function as the "central command" for a glucose meter used by an insulin-dependent diabetic patient. - FDA approved drugs. A 2017 New York Times article described that for the first time, the FDA has approved a digital pill, specifically, a medication embedded with a sensor that can tell doctors whether, and when, patients take their medicine. This approval marks a significant advance in the growing field of digital devices designed to monitor medicine-taking and to address the issue of patients not taking drugs as prescribed. The article notes that experts estimate that so-called nonadherence or noncompliance to medication costs about $100 billion a year because patients get sicker and need additional treatment or hospitalization. Patients who agree to take the digital medication can sign consent forms allowing their doctors and up to four other people, including family members, to receive electronic data showing the date and time pills are ingested. A smartphone app will allow patients to block recipients anytime they change their mind. Although voluntary, the technology is still likely to prompt questions about privacy and whether patients might feel pressured to take medication in a form their doctors can monitor. The article also notes that companies are developing digital medication technologies, including another ingestible sensor and visual recognition technology capable of confirming whether a patient has placed a pill on the tongue and has swallowed it and not all will need regulatory clearance, and some are already being used or tested in patients with heart problems, stroke, HIV, diabetes and other conditions.
A 2016 Vanderbilt Journal of Entertainment and Technology Law article, titled “Just What the Doctor Ordered: Protecting Privacy Without Impeding Development of Digital Pills,” analyzed digital pills in the context of the privacy and data security implications that could put consumers at risk. Digital pills that send information from places like the human digestive tract or bloodstream are being developed, with a few already in use. These pills could stand to provide information that could drastically improve the lives of many people, but they also have privacy and data security implications that could put consumers at great risk. The article notes that ingestible sensors have great potential to provide financial and health related benefits. The risks of the digital pill with regard to privacy and data security, however, may lead some to call for preemptive regulation. The article contends that rather than immediately limiting information use, policymakers should focus on improving the methods by which consumers can be educated and give consent. The article also states that it is not clear which privacy laws will actually apply to digital pills as HIPAA applies only to individually identifiable health information that is stored or transmitted by "covered entities" and their "business associates." Covered entities are usually health care providers, health insurers, or health care clearinghouses that process billing information, not pharmaceutical companies. Pharmaceutical companies can be considered "business associates" if they perform "functions or activities on behalf of, or certain services for, a covered entity that involve the use or disclosure of protected health information.
- Mobile medical apps. The FDA encourages the development of mobile medical apps (MMAs) that improve health care and provide consumers and health care professionals with valuable health information. The FDA also has a public health responsibility to oversee the safety and effectiveness of medical devices, including MMAs.
- SUPPORT. The California Telehealth Policy Coalition writes that this bill would provide Californians with added privacy protections that can help to safeguard their data and extend protections to the burgeoning field of FDA-approved digital health products. The National Association of Social Workers, California Chapter, states that despite digital health’s potential for a positive impact, there are significant concerns related to privacy and data security, which may act as barriers to its success. This bill would ensure that personal health information collected by these digital products is subject to CMIA, thereby ensuring patient privacy protections, while still allowing for the sharing of health information, as necessary, for the diagnosis and treatment of patients. CMIA provides that any individually identifiable information in the possession of a provider of health care regarding a patient’s medical history, mental or physical condition, or treatment is “medical information,” this bill would protect personal health information collected by these apps under CMIA, even when generated in a traditional health care setting.
- SUPPORT IF AMENDED. Consumer Reports (CR) writes that CR supported earlier versions of this bill because it would protect sensitive information generated by new forms of health technology, aligning privacy rights around data collected in new ways with all other medical information, and would also require that manufacturers apply appropriate data security standards. CF welcomes the intent of the amendment to last year’s bill, AB 384, introduced on June 25, 2019, which expanded the scope of the bill to include a wide range of health technology rather than limiting protections to users of digital feedback systems. Although CR strongly support broadening the scope of this bill, this bill limits the application of this bill to health technology that is both FDA-approved and used at the direction of a healthcare provider, is overly restrictive and risks significant confusion.
- OPPOSITION. A coalition of opposition writes that innovation in the medical technology industry benefits patients and our healthcare system, with the promise of producing millions in savings. This bill would increase compliance, legal and other administrative costs, while discouraging investment in this beneficial technology, without evidence of a well-documented problem in the already heavily regulated space of connected medical technology. This bill could therefore be a solution in search of a problem and creating unintended consequences for emerging technologies that could help to dramatically improve patient care.
- RELATED LEGISLATION. AB 2520 (Chiu) entitles an employee, of a nonprofit legal services entity representing a patient, to a copy, at no charge, of the relevant portion of the patient’s records that are needed to support a claim regarding eligibility for specified public benefit programs. Expands the definition of a public benefit program to include the Cash Assistance Program for Aged, Blind, and Disabled Legal Immigrants, and a government-funded housing subsidy or tenant-based housing assistance program. Requires a health care provider to provide the records at no charge upon proof that the records are needed for a petition for U nonimmigrant status under the Violence Against Women Act. AB 2520 is pending in Assembly Health Committee.
- PREVIOUS LEGISLATION.
- AB 384 (Chau) of 2019 was substantially similar to this bill and died in the Senate Appropriations Committee.
- AB 2167 (Chau) of 2018 would have amended CMIA to include within the definition of medical information, any information in possession of, or derived from, a digital health feedback system. Would have required manufacturers or operators that sell devices or applications that may be used as part of these digital health feedback systems to equip them with reasonable security features, as specified. AB 2167 failed on the Senate Floor.
- AB 2935 (Chau) of 2018 would have prohibited an operator of a commercial health monitoring program (CHMP) from intentionally sharing, selling, or disclosing individually identifiable health monitoring information in its possession or derived from a CHMP without first obtaining the consumer’s consent. AB 2935 was never heard in Senate Judiciary Committee.
- AB 375 (Chau), Chapter 55, Statutes of 2018, enacts the California Consumer Privacy Act of 2018, and grants a consumer a right to request a business to disclose the categories and specific pieces of personal information that it collects about the consumer, the categories of sources from which that information is collected, the business purposes for collecting or selling the information, and the categories of third parties with which the information is shared.
- SB 1121 (Dodd), Chapter 735, Statutes of 2018, modifies the California Consumer Privacy Act of 2018, by requiring a business that collects personal information about a consumer to disclose the consumer’s right to delete personal information in a form that is reasonably accessible to consumers, as specified.
- AB 2688 (Gordon) of 2016 would have prohibited an operator of a CHMP from intentionally sharing, selling, or disclosing individually identifiable health monitoring information in possession of or derived from a commercial health monitoring program to a third party, as defined, without first
providing clear and conspicuous notice and obtaining the consumer’s affirmative consent, as provided, and would have provided that individually identifiable information may be disclosed to specified entities without consent under specified circumstances, including to a government official if necessary to prevent an emergency involving the danger of death or serious physical injury to a person, if the disclosing entity provides notice of the disclosure as soon as practicable. AB 2688 would have also required an employer that receives health monitoring information in possession of or derived from a commercial health monitoring program to establish procedures to preserve the confidentiality and security of that information, as provided. AB 2688 died on the Senate third reading file. - SB 138 (Ed Hernandez), Chapter 444, Statutes of 2014, specifies the manner in which a health care service plan or health insurer is required to maintain confidentiality of medical information regarding the treatment of an insured, subscriber, or enrollee.
- AB 2747 (Committee on Judiciary), Chapter 913, Statutes of 2014, extends CMIA provisions to any business that offers software or hardware to consumers, including a mobile application or other related device that is designed to maintain medical information in order to make the information available to an individual or a provider of health care at the request of the individual or a provider of health care.
- AB 658 (Calderon), Chapter 296, Statutes of 2013, applies the prohibitions of the CMIA to any business that offers software or hardware to consumers, including a mobile application or other related device that is designed to maintain medical information to allow an individual to manage his or her information, or for the diagnosis, treatment, or management of a medical condition of the individual.
- AB 1298 (Jones), Chapter 699, Statutes of 2007, applies the prohibitions of the CMIA to any business organized for the purpose of maintaining medical information to allow an individual to manage his or her information, or for the treatment or diagnosis of the individual.
REGISTERED SUPPORT / OPPOSITION:
Support
California Telehealth Policy Coalition
National Association of Social Workers, California Chapter
Oakland Privacy
Opposition
Advanced Medical Technology Association
CalChamber
California Life Sciences Association
Analysis Prepared by: Kristene Mapile / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):